ePoster

HUMAN CORTICO-HIPPOCAMPAL ASSEMBLOIDS.<EM> </EM><EM>A NOVEL TOOL FOR ALZHEIMER’S DISEASE RESEARCH</EM>

Alba Ortega Gascóand 5 co-authors

Institut de Neurociències, Universitat de Barcelona

FENS Forum 2026 (2026)
Barcelona, Spain
Board PS04-08PM-151

Presentation

Date TBA

Board: PS04-08PM-151

Poster preview

HUMAN CORTICO-HIPPOCAMPAL ASSEMBLOIDS.<EM> </EM><EM>A NOVEL TOOL FOR ALZHEIMER’S DISEASE RESEARCH</EM> poster preview

Event Information

Poster Board

PS04-08PM-151

Abstract

The cortico-hippocampal pathway plays a crucial role in memory formation. Despite recent advances, the mechanisms involved in the establishment of the cortico-hippocampal connectivity and its alterations in Alzheimer’s disease (AD) remain poorly understood, being the lack in vitro models one of the major challenges. We have developed a reliable in vitro model that replicates the development and functionality of the cortico-hippocampal pathway.
We derived and characterized cortical and hippocampal organoids from human induced pluripotent stem cells (hiPSCs). To model the cortico-hippocampal pathway, we combined these region-specific organoids into assembloids. Interregional connectivity was assessed using axonal projection analysis and monosynaptic tracing, revealing the formation of reciprocal projections and the establishment of functional circuits between cortical and hippocampal regions. Neuronal activity analysis showed robust spontaneous activity and high connectivity in cortical organoids, whereas hippocampal organoids exhibited minimal activity when cultured alone, consistent with the input-dependent nature of hippocampal circuits. Notably, integration into cortico-hippocampal assembloids led to a marked increase in hippocampal neuronal activity driven by cortical input, closely mirroring in vivo hippocampal dynamics and highlighting the physiological relevance of the model. To further enhance biological fidelity, microglial cells were incorporated into the organoids, where they successfully integrated, remained active and modulated neuronal activity. Finally, tau pathology is being induced to investigate circuit-level vulnerability and mechanisms of tau spreading in AD.
In summary, we present a robust and reproducible model of the cortico-hippocampal pathway that provides a powerful platform to investigate AD and support the development of new therapeutic strategies.

Recommended posters

MODELING ALZHEIMER’S DISEASE WITH HUMAN CEREBRAL ORGANOIDS: RECAPITULATING PATHOLOGY AND PROTEOMIC BIOMARKERS

Patricia Mateos Martínez, Rosa González-Sastre, Milagros González-Flores, Cristina Soriano-Amador, Sabela Martín-Benito, Victoria López-Alonso, Raquel Coronel, Isabel Liste

3D HUMAN NEUROIMMUNE ORGANOID MODEL OF SPORADIC ALZHEIMER’S DISEASE REVEALS AMYLOID-DRIVEN NETWORK DYSFUNCTION

Akash Mali, Polina Abushik, Paula Korhonen, Anssi Pelkonen, Nataliia Novosolova, Mireia Gómez-Budia, Mohammad Rezaie, Kariem Ezzat, Tuomas Rauramaa, Ville Leinonen, Tarja Malm*

HUMAN CORTICAL ORGANOID MODELS REVEAL AN AMYLOID-BETA-INDEPENDENT RESPONSE PHENOTYPE IN EARLY ALZHEIMER’S DISEASE

Mathilde Colinet, Alessia Cambier, Gerald Masset, Bernard Coumans, Laurent Nguyen, Ira Espuny Camacho

MODELING ALZHEIMER'S DISEASE USING ORGANOIDS DERIVED FROM ADULT NEURAL STEM CELLS

Nour Chakroun Lamiri, John Wesley Ephraim, Maya Moubarak, Yousra Laouarem, Alain Buisson

ENGINEERING A MULTICELLULAR NEUROIMMUNE COMPETENT HUMAN BRAIN ORGANOID MODEL FOR ALZHEIMER’S DISEASE

Sergio Helgueta Romero, Gérald Masset, Mathilde Colinet, Alessia Cambier, Fatemeh Ghanavatinejad, Nayila Amdad, Abril Garrido, Bernard Coumans, Laurent Nguyen, Ira Espuny-Camacho

HUMAN HIPPOCAMPAL ORGANOID MODEL OF EARLY ALZHEIMER’S DISEASE REVEALS MITOCHONDRIAL HYPERMETABOLISM

Jesus Alarcon Gil, Dina Medina-Vera, Steven Edwards, Aphrodite Demetriou, Amelia Raluca Irimies, Srishti Sathyanarayanan, Ming Ho Choi, Ivan Nalvarte, Maria Ankarcrona, Luis E. Arroyo-García, Hjalmar Brismar, Luana Naia

Cookies

We use essential cookies to run the site. Analytics cookies are optional and help us improve World Wide. Learn more.